Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Xenon

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 105Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Xenon Reports Q2 2024 Financial Results and Business Update
    Xenon Reports Q2 2024 Financial Results and Business Update

    08 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/08/2927285/33485/en/Xenon-Reports-Q2-2024-Financial-Results-and-Business-Update.html

    GLOBENEWSWIRE
    08 Aug 2024
    Share Share
    Xenon Pharma: Phase 2 Azetukalner Data In Depression At ASCP 2024
    Xenon Pharma: Phase 2 Azetukalner Data In Depression At ASCP 2024

    28 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/28/2889029/33485/en/Xenon-Pharmaceuticals-Presents-Data-from-Phase-2-X-NOVA-Clinical-Trial-of-Azetukalner-in-Major-Depressive-Disorder-at-the-American-Society-of-Clinical-Psychopharmacology-2024-Annua.html

    GLOBENEWSWIRE
    28 May 2024
    Share Share
    Polarean's Xenon MRI to be Featured at Upcoming ATS 2024 Conference
    Polarean's Xenon MRI to be Featured at Upcoming ATS 2024 Conference

    08 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/08/2877885/0/en/Polarean-s-Xenon-MRI-to-be-Featured-at-Upcoming-ATS-2024-Conference.html

    GLOBENEWSWIRE
    08 May 2024
    Share Share
    Xenon Q1 2024 Call/Webcast, Corporate Update
    Xenon Q1 2024 Call/Webcast, Corporate Update

    02 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/02/2874645/33485/en/Xenon-Pharmaceuticals-Announces-Conference-Call-and-Webcast-to-Discuss-First-Quarter-2024-Financial-Results-and-Provide-Corporate-Update.html

    GLOBENEWSWIRE
    02 May 2024
    Share Share
    Xenon finally finds a way forward with epilepsy win
    Xenon finally finds a way forward with epilepsy win

    04 Oct 2021

    // Amy Brown EVALUATE

    https://www.evaluate.com/vantage/articles/news/snippets/xenon-finally-finds-way-forward-epilepsy-win

    Amy Brown EVALUATE
    04 Oct 2021
    Share Share
    Xenon Announces Positive Topline Results from Phase 2b ‘X-TOLE’ Trial of XEN1101
    Xenon Announces Positive Topline Results from Phase 2b ‘X-TOLE’ Trial of XEN1101

    04 Oct 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/10/04/2307753/33485/en/Xenon-Pharmaceuticals-Announces-Positive-Topline-Results-from-Phase-2b-X-TOLE-Clinical-Trial-of-XEN1101-for-the-Treatment-of-Focal-Epilepsy.html

    GLOBENEWSWIRE
    04 Oct 2021
    Share Share